Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product

Summary

This Pivotal study investigated the bioavailability in women of 2 tablet formulations containing Desogestrel 0.075 mg. The Pivotal study was performed at a single site with 30 subjects. Participants took 2 tablets of the test product and reference product in 2 periods and 2 sequences (either test after reference or reference after test). There was a washout of 14 days between each study period.

Timeline

Start

2020-01-11

Primary completion

2020-01-11

Completion

2020-01-28

Drugs

Indications

No indication recorded.